# Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People

> **NCT00543647** · PHASE1 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Fenofibrate 160 mg tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00543647
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2003-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543647, "Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00543647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*